Sanjivani Paranteral Limited Q3FY24 PAT at Rs 1.65 crore registers 73% YoY growth
February 07, 2024, Mumbai – Sanjivani Paranteral Limited (BSE: 531569), a pharmaceutical company, specializing in the manufacturing and distribution of high-quality parenteral and oral solid products, announced its unaudited financial…